Form 4 holding
Chairman and Chief Executive Officer, Director
Xeris Biopharma Holdings, Inc.
- Security class
- Common Stock
- Shares / value
- 3,788,064
- Estimated value
- $7,083,680
- Report date
- 31 Jan 2024
- Price
- $1.87
- Ownership
- Direct